Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance: Understanding SCLC heterogeneity and plasticity in metastasis and chemoresistance

Small cell lung cancer (SCLC) accounts for approximately 15% of all lung cancer cases and features a strong predilection for early metastasis and extremely poor prognosis. Despite being highly sensitive to chemotherapy and/or radiotherapy initially, most SCLC patients develop therapeutic resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yujuan, Chen, Yanxu, Qin, Zhen, Hu, Liang, Guo, Chenchen, Ji, Hongbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326415/
https://www.ncbi.nlm.nih.gov/pubmed/37249335
http://dx.doi.org/10.3724/abbs.2023080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326415/
https://www.ncbi.nlm.nih.gov/pubmed/37249335
http://dx.doi.org/10.3724/abbs.2023080

Ejemplares similares